IBM, Pfizer design AI model to predict Alzheimer's in seemingly healthy patients

• IBM (IBM +0.4%) and Pfizer (PFE +1.0%) have published research in The Lancet eClinicalMedicine outlining the duo's AI-backed approach to diagnosing Alzheimer's years before symptoms occur.
• The researches developed an AI model that uses samples of language data (obtained from clinical cognitive verbal tests) to predict with 71% accuracy the eventual onset of the disease within seemingly healthy people who don't have any Alzheimer's risk factors.
• IBM says the "work is part of a larger platform IBM Research is building to better understand neurological health and chronic illnesses through biomarkers and signals in speech and language."
• https://seekingalpha.com/news/3625002-ibm-pfizer-design-ai-model-can-predict-alzheimers-in-seemingly-healthy-patients